These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 17028220)
1. Serologic evaluation of patients from Missouri with erythema migrans-like skin lesions with the C6 Lyme test. Philipp MT; Masters E; Wormser GP; Hogrefe W; Martin D Clin Vaccine Immunol; 2006 Oct; 13(10):1170-1. PubMed ID: 17028220 [TBL] [Abstract][Full Text] [Related]
2. Southern tick-associated rash illness: erythema migrans is not always Lyme disease. Blanton L; Keith B; Brzezinski W South Med J; 2008 Jul; 101(7):759-60. PubMed ID: 18580719 [TBL] [Abstract][Full Text] [Related]
3. Microbiologic evaluation of patients from Missouri with erythema migrans. Wormser GP; Masters E; Liveris D; Nowakowski J; Nadelman RB; Holmgren D; Bittker S; Cooper D; Wang G; Schwartz I Clin Infect Dis; 2005 Feb; 40(3):423-8. PubMed ID: 15668867 [TBL] [Abstract][Full Text] [Related]
4. Prospective study of serologic tests for lyme disease. Steere AC; McHugh G; Damle N; Sikand VK Clin Infect Dis; 2008 Jul; 47(2):188-95. PubMed ID: 18532885 [TBL] [Abstract][Full Text] [Related]
5. Prospective clinical evaluation of patients from Missouri and New York with erythema migrans-like skin lesions. Wormser GP; Masters E; Nowakowski J; McKenna D; Holmgren D; Ma K; Ihde L; Cavaliere LF; Nadelman RB Clin Infect Dis; 2005 Oct; 41(7):958-65. PubMed ID: 16142659 [TBL] [Abstract][Full Text] [Related]
8. Antibody responses to borrelia IR(6) peptide variants and the C6 peptide in Swedish patients with erythema migrans. Tjernberg I; Sillanpää H; Seppälä I; Eliasson I; Forsberg P; Lahdenne P Int J Med Microbiol; 2009 Aug; 299(6):439-46. PubMed ID: 19138558 [TBL] [Abstract][Full Text] [Related]
9. Physician-diagnosed erythema migrans and erythema migrans-like rashes following Lone Star tick bites. Masters E; Granter S; Duray P; Cordes P Arch Dermatol; 1998 Aug; 134(8):955-60. PubMed ID: 9722725 [TBL] [Abstract][Full Text] [Related]
10. Impact of clinical variables on Borrelia burgdorferi-specific antibody seropositivity in acute-phase sera from patients in North America with culture-confirmed early Lyme disease. Wormser GP; Nowakowski J; Nadelman RB; Visintainer P; Levin A; Aguero-Rosenfeld ME Clin Vaccine Immunol; 2008 Oct; 15(10):1519-22. PubMed ID: 18716009 [TBL] [Abstract][Full Text] [Related]
11. Erythema migrans-like rash illness at a camp in North Carolina: a new tick-borne disease? Kirkland KB; Klimko TB; Meriwether RA; Schriefer M; Levin M; Levine J; Mac Kenzie WR; Dennis DT Arch Intern Med; 1997 Dec 8-22; 157(22):2635-41. PubMed ID: 9531233 [TBL] [Abstract][Full Text] [Related]
12. Cellular and humoral immune responses to Borrelia burgdorferi antigens in patients with culture-positive early Lyme disease. Vaz A; Glickstein L; Field JA; McHugh G; Sikand VK; Damle N; Steere AC Infect Immun; 2001 Dec; 69(12):7437-44. PubMed ID: 11705918 [TBL] [Abstract][Full Text] [Related]
13. STARI, or Masters disease: Lone Star tick-vectored Lyme-like illness. Masters EJ; Grigery CN; Masters RW Infect Dis Clin North Am; 2008 Jun; 22(2):361-76, viii. PubMed ID: 18452807 [TBL] [Abstract][Full Text] [Related]
14. Solitary erythema migrans in Georgia and South Carolina. Felz MW; Chandler FW; Oliver JH; Rahn DW; Schriefer ME Arch Dermatol; 1999 Nov; 135(11):1317-26. PubMed ID: 10566829 [TBL] [Abstract][Full Text] [Related]
15. [Comparison of test with antigen VlsE (C6) with tests with recombinant antigens in patients with Lyme borreliosis]. Zajkowska JM; Kondrusik M; Pancewicz SA; Grygorczuk S; Jamiołkowski J; Stalewska J Pol Merkur Lekarski; 2007 Aug; 23(134):95-9. PubMed ID: 18044336 [TBL] [Abstract][Full Text] [Related]
16. The clinical spectrum of early Lyme borreliosis in patients with culture-confirmed erythema migrans. Nadelman RB; Nowakowski J; Forseter G; Goldberg NS; Bittker S; Cooper D; Aguero-Rosenfeld M; Wormser GP Am J Med; 1996 May; 100(5):502-8. PubMed ID: 8644761 [TBL] [Abstract][Full Text] [Related]
17. Hitting the target: Lyme or STARI? Goldstein IM; Black MA; Leydet B; Vidrine SB J La State Med Soc; 2013; 165(2):83-7. PubMed ID: 23734537 [TBL] [Abstract][Full Text] [Related]
18. Report of Non-Lyme, Erythema Migrans Rashes from New Jersey with a Review of Possible Role of Tick Salivary Toxins. Kannangara DW; Patel P Vector Borne Zoonotic Dis; 2018 Dec; 18(12):641-652. PubMed ID: 30129909 [TBL] [Abstract][Full Text] [Related]
19. Immune complexes in early Lyme disease. Lencáková D; Stefancíková A; Ivanová R; Petko B Can J Microbiol; 2007 Dec; 53(12):1375-7. PubMed ID: 18059570 [TBL] [Abstract][Full Text] [Related]
20. Laboratory diagnostic techniques for patients with early Lyme disease associated with erythema migrans: a comparison of different techniques. Nowakowski J; Schwartz I; Liveris D; Wang G; Aguero-Rosenfeld ME; Girao G; McKenna D; Nadelman RB; Cavaliere LF; Wormser GP; Clin Infect Dis; 2001 Dec; 33(12):2023-7. PubMed ID: 11700579 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]